Topics

Glioblastoma | Treatment | Chemotherapy | Temozolomide | Targeted Therapy

Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Temozolomide > Targeted Therapy

Brown NF, McBain C, Brazil L, Peoples S, Jefferies S, Harris F, Vinayan A, Plaha P, Brooks C, Hussain S, Dutton SJ, Cook J, Ng SM, Levy S, Coutts T, Mulholland P.
Ipilimumab with temozolomide vs. temozolomide alone after surgery and chemoradiotherapy in recently diagnosed glioblastoma: a randomized phase II clinical trial.
Neurooncol Adv. 2025 May 26;7(1):vdaf032. doi: 10.1093/noajnl/vdaf032. PMID: 40800123. Interventional study. ˍ

Chen D, Le SB, Ghiaseddin AP, Manektalia H, Li M, O'Dell A, Rahman M, Tran DD.
Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study.
Med. 2025 Jun 3:100708. doi: 10.1016/j.medj.2025.100708. PMID: 40466642. Interventional study. ˍ